
Global Obesity Trends Show Signs of Slowing in Wealthier Nations, New Research Reveals
A landmark study suggests rising obesity rates are not inevitable, with several high-income countries showing plateaus or potential declines.
Global Obesity Trends Show Signs of Slowing in Wealthier Nations
A sweeping new study has found that an unrelenting global rise in obesity may not be the unavoidable outcome many researchers once feared. According to the research, several countries are now witnessing a slowdown, stabilisation, or even a possible reversal in obesity rates — a finding that challenges the narrative of an unstoppable worldwide epidemic.
What the Research Found
Published in the journal Nature, the study was conducted by an international collaboration involving nearly 2,000 researchers. The team analysed data from 4,050 population-based studies encompassing 232 million participants aged five and older. For each country examined, researchers tracked annual changes in obesity prevalence spanning 45 years, from 1980 through to 2024.
While obesity rates did increase across virtually every country during this period, the pattern was far from uniform. In the majority of high-income nations, the sharp upward trajectory of earlier decades has given way to a more gradual rise, a levelling off, or in some instances, a tentative decline.
Country-by-Country Breakdown
The figures paint a detailed picture of how different nations are faring:
- United States and United Kingdom: The pace of obesity growth is decelerating, with adult prevalence reaching approximately 40–43% and 27–30% respectively in 2024.
- France: Obesity rates may have begun to fall, with roughly 11–12% of adults affected.
- Germany: Rates appear to have plateaued, affecting around 20–23% of adults.
- Finland: Obesity continues to rise steadily among adults.
Among children and adolescents, the slowdown has often preceded that seen in adults. In Denmark, for example, the deceleration in youth obesity began as early as 1990. Across most high-income nations, rates among young people stabilised around the mid-2000s. In the UK, US, Germany, and Japan, obesity in children and teenagers has plateaued at rates of 10–12%, 20–23%, 7–12%, and 3–7% respectively.
A Different Story in Developing Nations
The picture is considerably more troubling in lower-income regions. Across many low- and middle-income countries, obesity rates among young people and adults continue to climb — and in some cases, the rate of increase is actually accelerating. Experts warn this trajectory could fuel significant rises in type 2 diabetes and cardiovascular disease in these populations.
Why Trends Differ So Widely
Professor Majid Ezzati of Imperial College London, one of the study's lead authors, emphasised that the diversity in trends is striking even among nations that share similar economic and technological characteristics.
"Countries may look the same on the surface, but obesity looks very different," he noted.
The researchers stress that understanding the drivers behind these varied trends is now a critical priority. While common factors — such as widespread access to processed foods and declining levels of physical activity — play a role across many nations, country-specific influences may be equally significant. These include cultural attitudes toward body image, socioeconomic conditions, and the presence or absence of targeted public health interventions such as nutritious school meal programmes.
Reasons for Cautious Optimism
Health experts responding to the findings acknowledged the encouraging signs emerging from certain countries. Understanding what policies and cultural factors have contributed to stabilisation could prove invaluable for shaping future public health strategies elsewhere.
Looking further ahead, researchers also highlighted the potential role of new weight-loss medications in reshaping obesity trends, particularly in the UK and United States. Early indications of stabilisation in the US have prompted some cautious optimism among scientists.
As one expert noted, combining clinically proven medicines with robust, population-level public health measures could be the key to meaningfully shifting obesity rates in the right direction — offering a more hopeful outlook than the relentlessly upward trend that has defined recent decades.


